Roles of platelets in tumor progression

doi:10.3760/cma.j.issn.1673422X.2018.02.010

Abstract

CHEN Luo-Jun, TIAN Jing-Yuan, LI Na, SONG Qi-Bin. Roles of platelets in tumor progression[J]. Journal of International Oncology, 2018, 45(2): 103-106.

［1］ Menter DG, Kopetz S, Hawk E, et al. Platelet "first responders" in wound response, cancer, and metastasis［J］. Cancer Metastasis Rev, 2017, 36(2): 199213. DOI: 10.1007/s1055501796820. ［2］ Ma XM, Sun X, Yang GW, et al. The platelettolymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a metaanalysis［J］. Climacteric, 2017, 20(5): 448455. DOI: 10.1080/13697137.2017.1326894. ［3］ Cho MS, Noh K, Haemmerle M, et al. Role of ADP receptors on platelets in the growth of ovarian cancer［J］. Blood, 2017, 130(10): 12351242. DOI: 10.1182/blood201702769893. ［4］ Yan M, Jurasz P. The role of platelets in the tumor microenvironment: from solid tumors to leukemia［J］. Biochim Biophys Acta, 2016, 1863(3): 392400. DOI: 10.1016/j.bbamcr.2015.07.008. ［5］ Cho MS, BottsfordMiller J, Vasquez HG, et al. Platelets increase the proliferation of ovarian cancer cells［J］. Blood, 2012, 120(24): 48694872. DOI: 10.1182/blood201206438598. ［6］ Takagi S, Takemoto A, Takami M, et al. Platelets promote osteosarcoma cell growth through activation of the plateletderived growth factor receptorAkt signaling axis［J］. Cancer Sci, 2014, 105(8): 983988. DOI: 10.1111/cas.12464. ［7］ RadziwonBalicka A, Medina C, O′driscoll L, et al. Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance［J］. Br J Pharmacol, 2012, 167(4): 787804. DOI: 10.1111/j.14765381.2012.01991.x. ［8］ Wang Z, Huang H. Platelet factor4 (CXCL4/PF4): an angiostatic chemokine for cancer therapy［J］. Cancer lett, 2013, 331(2): 147153. DOI: 10.1016/j.canlet.2013.01.006. ［9］ Weber MR, Zuka M, Lorger M, et al. Activated tumor cell integrin αvβ3 cooperates with platelets to promote extravasation and metastasis from the blood stream［J］. Thromb Res, 2016, 140(Suppl 1): S27S36. DOI: 10.1016/s00493848(16)300950. ［10］ Soares KC, Rucki AA, Kim V, et al. TGFβ blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner［J］. Oncotarget, 2015, 6(40): 4300543015. DOI: 10.18632/oncotarget.5656. ［11］ Maj T, Wang W, Crespo J, et al. Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PDL1blockade resistance in tumor［J］. Nat Immunol, 2017, 18(12): 13321341. DOI: 10.1038/ni.3868. ［12］ Wang S, Zhang Y, Cong W, et al. Breast cancer stemlike cells can promote metastasis by activating platelets and downregulating antitumor activity of natural killer cells［J］. J Tradit Chin Med, 2016, 36(4): 530537. ［13］ Placke T, rgel M, Schaller M, et al. Plateletderived MHC classⅠconfers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cells［J］. Cancer Res, 2012, 72(2): 440448. DOI: 10.1158/00085472.CAN111872. ［14］ Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches［J］. Proc Natl Acad Sci U S A, 2014, 111(30): E3053E3061. DOI: 10.1073/pnas.1411082111. ［15］ Schumacher D, Strilic B, Sivaraj KK, et al. Plateletderived nucleotides promote tumorcell transendothelial migration and metastasis via P2Y2 receptor［J］. Cancer Cell, 2013, 24(1): 130137. DOI: 10.1016/j.ccr.2013.05.008. ［16］ Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis［J］. Cell, 2017, 168(4): 670691. DOI: 10.1016/j.cell.2016.11.037. ［17］ Takemoto A, Okitaka M, Takagi S, et al. A critical role of platelet TGFβ release in podoplaninmediated tumour invasion and metastasis［J］. Sci Rep, 2017, 7: 42186. DOI: 10.1038/srep42186. ［18］ Zhang P, Goodrich C, Fu C, et al. Melanoma upregulates ICAM1 expression on endothelial cells through engagement of tumor CD44 with endothelial Eselectin and activation of a PKCαp38SP1 pathway［J］. FASEB J, 2014, 28(11): 45914609. DOI: 10.1096/fj.11202747. ［19］ Wojtukiewicz MZ, Sierko E, Hempel D, et al. Platelets and cancer angiogenesis nexus［J］. Cancer Metastasis Rev, 2017, 36(2): 249262. DOI: 10.1007/s1055501796731. ［20］ Kuznetsov HS, Marsh T, Markens BA, et al. Identification of luminal breast cancers that establish a tumorsupportive macroenvironment defined by proangiogenic platelets and bone marrowderived cells［J］. Cancer Discov, 2012, 2(12): 11501165. DOI: 10.1158/21598290.cd120216. ［21］ Kut C, Mac Gabhann F, Popel AS. Where is VEGF in the body? A metaanalysis of VEGF distribution in cancer［J］. Br J Cancer, 2007, 97(7): 978985. ［22］ Oza AM, Cook AD, Pfisterer J, et al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial［J］. Lancet Oncol, 2015, 16(8): 928936. DOI: 10.1016/s14702045(15)000868. ［23］ Sharpe K, Stewart GD, Mackay A, et al. The effect of VEGFtargetedtherapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer［J］. Clin Cancer Res, 2013, 19(24): 69246934. DOI: 10.1158/10780432.ccr131631. ［24］ Haemmerle M, BottsfordMiller J, Pradeep S, et al. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal［J］. J Clin Invest, 2016, 126(5): 18851896. DOI: 10.1172/jci85086. ［25］ GuillemLlobat P, Dovizio M, Bruno A, et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells［J］. Oncotarget, 2016, 7(22): 3246232477. DOI: 10.18632/oncotarget.8655. ［26］ Algra AM, Rothwell PM. Effects of regular aspirin on longterm cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials［J］. Lancet Oncol, 2012, 13(5): 518527. DOI: 10.1016/s14702045(12)701122. ［27］ Gebremeskel S, LeVatte T, Liwski RS, et al. The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer［J］. Int J Cancer, 2015, 136(1): 234240. DOI: 10.1002/ijc.28947. ［28］ Krenzlin H, Lorenz V, Alessandri B. The involvement of thrombin in the pathogenesis of glioblastoma［J］. J Neurosci Res, 2017, 95(10): 20802085. DOI: 10.1002/jnr.24049. ［29］ Echtler K, Konrad I, Lorenz M, et al. Platelet GPⅡb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis［J］. PLoS One, 2017, 12(3): e0172788. DOI: 10.1371/journal.pone.0172788. ［30］ Lian L, Li W, Li ZY, et al. Inhibition of MCF7 breast cancer cellinduced platelet aggregation using a combination of antiplatelet drugs［J］. Oncol Lett, 2013, 5(2): 675680. DOI: 10.3892/ol.2012.1074. ［31］ Li S, Zhang Y, Wang J, et al. Nanoparticlemediated local depletion of tumourassociated platelets disrupts vascular barriers and augments drug accumulation in tumours［J］. Nature Biomed Eng, 2017, 1(8): 667679. DOI: 10.1038/s4155101701158.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.

Roles of platelets in tumor progression

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments